Feasibility of Bridge for Post-Operative Pain Management in Hip Arthroplasty

October 3, 2025 updated by: Masimo Corporation
The aim of this research study is to gather data regarding the feasibility of the Bridge system for the management of pain following total hip arthroplasty (THA).

Study Overview

Status

Terminated

Conditions

Study Type

Interventional

Enrollment (Actual)

5

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15232
        • University of Pittsburgh Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Subject is 18 years of age or older
  • Subject scheduled for elective primary unilateral total hip arthroplasty (THA)
  • Subject opioid use is less than 60 milligram morphine equivalent for the last 30 days
  • Subject has given written informed consent to participate in the study

Exclusion Criteria:

  • Subjects who are pregnant or breastfeeding
  • Subjects with cardiac pacemakers or other implanted devices (e.g. vagal nerve simulators), hemophilia or psoriasis vulgaris
  • Subjects with a history of active depression, anxiety or catastrophizing
  • Subjects with active alcoholism or drug abuse
  • Subjects with severe chronic pain condition that requires daily preoperative opioid dependence
  • Subjects deemed not suitable for the study at the discretion of the principal investigator
  • Subjects who are concurrently participating in any other research study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Bridge device
The active Bridge device delivers electrical stimulation to the cranial and occipital nerves.
Bridge is a percutaneous nerve field stimulation device which uses alternating currents of stimulation over a large field and with higher voltage in order to influence central pain areas.
Sham Comparator: Sham device
The sham device has the same appearance and will require the same placement technique as the Bridge (active) device but will not deliver electrical impulses
The sham device has the same appearance and will require the same placement technique as the Bridge (active) device but will not deliver electrical impulses.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Total Opioid Consumption Between Active and Sham Arms.
Time Frame: Day of surgery to Day 5 (120 hours) post-op
The sample size is well below the threshold needed to reliably assess outcomes and perform statistical comparisons. As a result, we have provided the raw data for comparison of opioid consumption between the two groups.
Day of surgery to Day 5 (120 hours) post-op

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Pain Between Active and Sham Arms as Measured Using the Numeric Rating Scale.
Time Frame: Day of surgery to Day 5 (120 hours) post-op
Pain scores using a numerical scale will be collected at rest and movement and will be obtained prior to surgery, in the recovery room, prior to leaving the recovery room, every 6 hours during the first 24 hrs, and at 48, 72, 96 and 120 hours post-operatively. Subjects will use a 0-10 numeric scale (0 indicating no pain and 10 indicating extreme pain).
Day of surgery to Day 5 (120 hours) post-op
Change in Postoperative Nausea Between Active and Sham Arms as Measured Using a Postoperative Nausea and Vomiting Rating Scale.
Time Frame: Day of surgery to Day 5 (120 hours) post-op
Postoperative nausea and vomiting will be evaluated from immediately after surgery through postoperative day 5, using a 0-10 scale (0 indicating no nausea and 10 indicating extreme nausea).
Day of surgery to Day 5 (120 hours) post-op
Change in Functional Recovery Between Active and Sham Arms Assessed Using the Timed Up and Go (TUG) Assessment Collected on Post-Op Day 30
Time Frame: Day of surgery to post-operative day 30.
Functional recovery will be assessed daily from day of surgery to post-op day 5, using the Timed Up and Go assessment to assess mobility.
Day of surgery to post-operative day 30.
Change in Functional Recovery Between Active and Sham Arms Assessed Using the 12-Item Short Form Survey (SF-12) Collected on Post-Op Day 30
Time Frame: Day of surgery to post-operative day 30.
Subjects will also complete the 12-Item Short Form Survey (SF-12) on Post-Op day 30 to evaluate quality of recovery.
Day of surgery to post-operative day 30.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 26, 2022

Primary Completion (Actual)

November 19, 2022

Study Completion (Actual)

May 24, 2023

Study Registration Dates

First Submitted

July 30, 2021

First Submitted That Met QC Criteria

August 17, 2021

First Posted (Actual)

August 24, 2021

Study Record Updates

Last Update Posted (Estimated)

October 21, 2025

Last Update Submitted That Met QC Criteria

October 3, 2025

Last Verified

October 1, 2025

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Postoperative

Clinical Trials on Bridge device

Subscribe